Industry Roundtable: Brains Behind Neurotech Discuss Innovation, Challenges Ahead (Part 3 of 3)
This article was originally published in The Pink Sheet Daily
Executive Summary
In this final installment of a three-part series, neurotechnology industry execs look into their crystal balls to describe how CNS therapies might develop in the next few decades.
You may also be interested in...
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 2 of 4)
In part II of a series, panelists discuss venture capital, NIH grants, SBIR and foundation funding, as ways to support discovery.
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 2 of 4)
In part II of a series, panelists discuss venture capital, NIH grants, SBIR and foundation funding, as ways to support discovery.
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps
In Part I of a series, panelists discuss outcomes measures in a sector with unique regulatory conditions and the need for biomarkers.